Dissemin is shutting down on January 1st, 2025

Published in

2016 IEEE 29th International Symposium on Computer-Based Medical Systems (CBMS)

DOI: 10.1109/cbms.2016.60

Links

Tools

Export citation

Search in Google Scholar

Early experiences in using blood cells biomembranes as markers for diabetes diagnosis

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Investigation of membrane fluidity by two photon fluorescence microscopy opens up a new and important area of translational research, being a useful and sensitive method for disease monitoring and treatment. In this paper we investigate if biomembranes in human red blood cells (RBC) and peripheral mononuclear cells (PMC) could be used as markers for type 1 diabetes mellitus (T1DM) diagnosis, leading to the development of a method for monitoring T1DM progression that nowadays is lacking, as clinical exams cannot pursue this task with enough reliability. To this aim, we present a set of features computed from PMC and RBC images that are given to a multi-experts system leveraging on multi-spectral information for positive/negative classifications. The experiments are carried out on a dataset of 800 blood cell images belonging to 18 subjects adopting the leave-one-person-out approach.